85
Views
37
CrossRef citations to date
0
Altmetric
Research Article

NEUROPEPTIDES MODULATE A MURINE MONOCYTE/MACROPHAGE CELL LINE CAPACITY FOR PHAGOCYTOSIS AND KILLING OF LEISHMANIA MAJOR PARASITES

, &
Pages 397-409 | Published online: 31 Jul 2001

REFERENCES

  • Russell D. G., Talamas-Rohana P. Leishmania and the macrophage: a marriage of inconvenience. Immunol. Today 1989; 10: 328
  • Celada A., Nathan C. Macrophage activation revisited. Immunol. Today 1994; 15: 100
  • Reiner N. E. Altered cell signaling and mononuclear phagocyte deactivation during intracellular infection. Immunol. Today 1994; 15: 374–381
  • Bogdan C., Gessner A., Röllinghoff M. Cytokines in leishmaniasis: A complex network of stimulatory and inhibitory interactions. Immunobiology 1993; 189: 356
  • O'Donnnell C. A., Liew F. Y. Immunology of leishmaniasis. Adv. Parasitol. 1993; 32: 161
  • Locksley R. M., Reiner S. L. The regulation of immunity to Leishmania major. Ann. Rev. Immunol. 1995; 13: 151
  • Carr D. J.J. neuroimmunoendocrinology, J. E. Blalock. Karger, Basel 1992; 84
  • Johnson H. M., Downs M. O., Pontzer C. H. neuroimmunoendocrinology, J. E. Blalock. Karger, Basel 1992; 49
  • De La Fuente M., Delgado M., Del Rio M., Garrido E., Leceta J., Hernanz A., Gomariz R. P. Vasoactive intestinal peptide modulation of adherence and mobility in rat peritoneal lymphocytes and macrophages. Peptides 1994; 15: 1157
  • Litwin D. K., Wilson A. K., Said S. I. Vasoactive intestinal peptide (VIP) inhibits rat alveolar macrophage phagocytosis and chemotaxis in vitro. Regul. Pept. 1992; 40: 63
  • De La Fuente M., Del Rio M., Ferrandez M. D., Hernanz A. Modulation of phagocytic function in murine peritoneal macrophages by bombesin, gastrin-releasing peptide and neuromedin C. Immunology 1991; 73: 205
  • De La Fuente M., Del Gaco M., Gomariz R. P. VIP modulation of immune cell functions. Adv. Neuroimmunol. 1996; 6: 75
  • Lotz M., Vaughan J. H., Carson D. A. Effect of neuropeptides on production of inflammatory cytokines by human monocytes. Science 1988; 421: 1218
  • Kimata H., Yoshida A., Ishioka C., Mikawa H. Differential effect of vasoactive intestinal peptide, somatostatin, and substance P on human IgE and IgG subclass production. Cell. Immunol. 1992; 144: 429
  • Blum A. M., Metwali A., Mathew R., Elliott D., Weinstock J. V. Substance P and somatostatin can modulate the amount of IgG2a secreted in response to Schistosome egg antigens in murine Schistosomiasis mansoni. J. Immunol. 1993; 151: 6994
  • Blalock J. E. neuroimmunoendocrinology system, J. E. Blalock. Karger, Basel 1992; 1
  • Weinstock J. V. Production of neuropeptides by inflammatory cells within the granulomas of murine Schistosomiasis mansoni. Eur. J. Clin. Invest. 1991; 21: 145
  • Leceta J., Martínez C., Delgado M., Garrid E. Expression of vasoactive intestinal peptide in lymphocytes: a possible endogenous role in the regulation of the immune system. Adv. Neuroimmunol. 1996; 6: 29
  • Weinstock J. V., Blum A. M., Malloy T. Macrophages within the granulomas of murine Schistoma mansoni are a source of a somatostatin 1–14-like molecule. Cell. Immunol. 1990; 131: 381
  • Goetzl E. J., Adelman D. C., Sreedharan S. P. Neuroimmunology. Adv. Immunol. 1990; 48: 161
  • Louis J. A., Moedder E., Behin H. D. Regulation of protozoan parasite antigens by murine T lymphocytes: 1. Induction of specific T lymphocyte-dependent proliferative response to Leishmania tropica. Eur. J. Immunol. 1979; 9: 841
  • Said S. I., Mutt V. Isolation from porcine-intestinal wall of a vasoactive octacosapeptide related to secretin and to glucagon. Eur. J. Biochem. 1972; 28: 199
  • Kiderlen A. F., Baccarini M., Lohman-Matthes M-L. A fast and objective assay for cell mediated intra- and extracellular killing of Leishmania promastigotes. J. Immunol. Methods 1986; 86: 199
  • Hall L. R., Titus R. G. Sand fly vector saliva selectively modulates macrophage functions that inhibit killing of Leishmania major and nitric oxide production. J. Immunol. 1995; 155: 3501
  • Montgomery D. C. Design and analysis of experiments. John Willey & Sons, New York 1991
  • Foris G., Gyimesi E., Komaromi I. The mechanism of antibody-dependent cellular cytotoxicity stimulation by somatostatin in rat peritoneal macrophages. Cell. Immunol. 1985; 90: 217
  • Sreedharan S. P., Kodama K. T., Peterson K. E., Goetzl E. J. Distinct subset of somatostatin receptors on cultured human lymphocytes. J. Biol. Chem. 1989; 264: 949
  • Scicchitano R., Dazin P., Bienenstock J., Payan D., Stanisz A. M. Distribution of somatostatin receptors on murine spleen and Peyer's patch T and B lymphocytes. Brain Behav. Immun. 1987; 1: 173
  • Umeda Y. Inhibition of immune response by CGRP. Ann. NY Acad. Sci. 1992; 657: 552
  • Mosser D. M., Handman E. Treatment of macrophage with IFN-γ inhibits their binding ability to Leishmania promastigotes. J. Leuko. Biol. 1992; 52: 369
  • Nong Y. H., Titus R. G., Ribeiro J. M.C., Remold H. G. Peptides encoded by calcitonin gene inhibit macrophage functions. J. Immunol. 1989; 143: 45
  • Owan I., Ibaraki K. The role of calcitonin gene-related peptide (CGRP) in macrophages: the presence of functional receptors and effects on proliferation and differentiation into osteoclast-like cells. Bone Miner 1994; 24: 151
  • Agro A., Stanisz A. M. Neuroimmunomodulation: classical and non-classical cellular activation. Adv. Neuroimmunol. 1995; 5: 311
  • Stenger S., Thüring H., Röllinghoff M., Bogdan C. Tissue expression of inducible oxide synthase is closely associated with resistance to Leishmania major. J. Exp. Med. 1994; 180: 783
  • Kincy-Cain T., Bost K. L. Substance P-induced IL-12 production by murine macrophages. J. Immunol. 1997; 158: 2334
  • Blum A. M., Metwali A., Cook G., Mathew R. C., Elliott D., Weinstock J. V. Substance P modulates antigen-induced, IFN-γ production in murine Schistosomiasis mansoni. J. Immunol. 1993; 151: 225
  • Ansel J. C., Brown J. R., Payan D. G., Brown M. A. Substance P selectively activates TNF-α gene expression in murine mast cells. J. Immunol. 1993; 150: 4478
  • Ichinose M., Sawada M., Maen T. Inhibitory effect of vasoactive intestinal peptide (VIP) on phagocytosis in mouse macrophages. Regul. Pept. 1994; 54: 457
  • De La Fuente M., Delgado M., Del Rio M., Martinez C., Hernanz A., Gomariz R. P. Stimulation by vasoactive intestinal peptide (VIP) of phagocytic function in rat macrophages. Protein kinase C involvement. Regul. Pept. 1993; 48: 345
  • WiiK P. Vasoactive intestinal peptide inhibits the respiratory burst in human monocytes by a cyclic AMP-mediated mechanism. Regul. Pept. 1989; 25: 187
  • Ottaway C. A., Bernaerts C., Chan B., Greenberg G. R. Specific binding of vasoactive intestinal peptide to human circulating mononuclear cells. Can. J. Physiol. Pharmacol. 1983; 61: 664
  • Muscettola M., Grass G. Somatostatin and vasoactive intestinal peptide reduce interferon gamma production by human peripheral blood mononuclear cells. Immunobiology 1990; 180: 419
  • Ahmed A. A., Mutt V., Nordlind K. Modulating effect of sensory and autonomic neuropeptides on murine splenocyte proliferation and cytokine secretion induced by Leishmania major. Immunopharmacol. Immunotoxicol. 1999; 21: 507
  • Chelmicka-Schorr E., Kwasniewski M. N., Czlonkowska A. Sympathetic nervous system modulates macrophage functions. Int. J. Immunopharmacol. 1992; 14: 841

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.